Literature DB >> 6897040

Vascular effects of the peptides PYY and PHI: comparison with APP and VIP.

J M Lundberg, K Tatemoto.   

Abstract

Local infusions of PYY (3-100 pmol.min-1) caused a slowly developing vasoconstriction of a long duration in the cat submandibular salivary gland. The vasoconstrictor action of PYY was also present after alpha-adrenoceptor blockade and in sympathectomized animals. Local APP infusions caused only weak vasoconstriction. Infusions of PHI and synthetic PHI caused an atropine-resistant submandibular vasodilation. On a molar basis PHI was, however, almost 1000-fold less potent than VIP as vasodilating agent.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6897040     DOI: 10.1016/0014-2999(82)90300-4

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  11 in total

1.  The effects of vasoactive intestinal polypeptide on gastric motility in the lamb.

Authors:  A M Reid; A Shulkes; D A Titchen
Journal:  J Physiol       Date:  1988-02       Impact factor: 5.182

2.  Peptide-immunoreactive nerves in the mammalian female genital tract.

Authors:  W M Huang; J Gu; M A Blank; J M Allen; S R Bloom; J M Polak
Journal:  Histochem J       Date:  1984-12

3.  A comparison of the differential effects of vasoactive intestinal peptide and peptide histidine isoleucine on the vascular and capsular smooth muscle of the dog spleen.

Authors:  R Corder; P G Withrington
Journal:  Br J Pharmacol       Date:  1988-10       Impact factor: 8.739

4.  Peptide YY (PYY) stimulates intrinsic enteric motor neurones in the rat small intestine.

Authors:  A Krantis; W Potvin; R K Harding
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-09       Impact factor: 3.000

Review 5.  Evolution of the restorative proctocolectomy and its effects on gastrointestinal hormones.

Authors:  Amosy E M'Koma; Paul E Wise; Roberta L Muldoon; David A Schwartz; Mary K Washington; Alan J Herline
Journal:  Int J Colorectal Dis       Date:  2007-06-19       Impact factor: 2.571

6.  Plasma peptide YY (PYY) in dumping syndrome.

Authors:  T E Adrian; R G Long; H S Fuessl; S R Bloom
Journal:  Dig Dis Sci       Date:  1985-12       Impact factor: 3.199

7.  Peptide histidine isoleucine: a secretagogue in human jejunum.

Authors:  A A Anagnostides; N D Christofides; K Tatemoto; V S Chadwick; S R Bloom
Journal:  Gut       Date:  1984-04       Impact factor: 23.059

8.  Effect of peptide histidine isoleucine on water and electrolyte transport in the human jejunum.

Authors:  K J Moriarty; J E Hegarty; K Tatemoto; V Mutt; N D Christofides; S R Bloom; J R Wood
Journal:  Gut       Date:  1984-06       Impact factor: 23.059

9.  Peptide histidine isoleucine (PHI). A secretagogue in porcine intestine.

Authors:  A A Anagnostides; K Manolas; N D Christofides; Y Yiangou; R B Welbourn; S R Bloom; V S Chadwick
Journal:  Dig Dis Sci       Date:  1983-10       Impact factor: 3.199

10.  Peptide histidine isoleucine-like immunoreactivity release from the rat gastric fundus.

Authors:  D Currò; P Preziosi; E Ragazzoni; G Ciabattoni
Journal:  Br J Pharmacol       Date:  1994-10       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.